Products launch on Debenhams.com

RNS Number : 7895D
Cellular Goods PLC
24 October 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Press release

 

24 October 2022

 

 

Cellular Goods PLC

 

('Cellular Goods' or 'the Company')

 

Products launch on Debenhams.com

 

Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce that its 'Look Better' (skincare) range will be available for purchase on Debenhams' online premium marketplace, Debenhams.com, from today.

 

Cellular Goods will initially offer eight of its cannabinoid-based skincare products on the online marketplace, making the Company the first cannabigerol (CBG)-based skincare brand to offer its products on Debenhams.com and contributing to Cellular Goods' efforts to continue building its sales channels. With high numbers of monthly visitors to Debenhams.com, this initiative will enable Cellular Goods to widen its reach and address demand for products that can help prevent the signs of skin ageing and sensitivity.

 

The commencement of sales on Debenhams.com follows the launch of shipping to the US, as well as the launch of Cellular Goods' four new gifting sets in the Company's new 'Gift Better' (gifting) range, for the festive season, in October.

 

Cellular Goods' products available on Debenhams.com include the new Rejuvenating Night Cream, SPF 25 Rejuvenating Day Cream and Rejuvenating Day Mousse, which contain the Company's proprietary formulation of cannabidiol (CBD) and CBG. Other Cellular Goods products available on the Debenhams marketplace include the Company's CBG-based Nourishing Cannabinoid Face Oil, Calming Cannabinoid After Shaving Moisturiser and Rejuvenating Face Serum, as well as all 'mini' sizes for all available 'Look Better' products.

 

Darcy Taylor, interim CEO of Cellular Goods, commented: " Debenhams is a household name, with millions of people visiting its online marketplace every month. By launching our products on the Debenhams ecommerce site, we are taking another step in our efforts to continue increasing Cellular Goods' visibility and expanding our sales channels. We are delighted that our products are now available on Debehams.com and we are excited to be working alongside them to help ensure their customers can more easily access our products and take advantage of all their outstanding benefits."

 

For further information please contact:

Cellular Goods


Darcy Taylor

Chairman

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

Tennyson Securities


Corporate Broker & Adviser

Peter Krens

Alan Howard

 

+44 207 186 9030

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427

Tancredi Intelligent Communication


Media Relations

Helen Humphrey

Gabriela Amaya Garcia

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 791 503 5294

+44 789 755 7112

 

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Feel Better, Look Better and Function Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD wellness, with the first products launched in December 2021. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PRLMJBATMTTTBLT

Companies

Cel AI (CLAI)
UK 100

Latest directors dealings